Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 24.51 | 24.51 | 1.96 | 1.96 | 0.46 |
| Share application money | 6.68 | 3.50 | - | - | - |
| Preference share capital | - | - | - | - | 1.50 |
| Reserves & surplus | 2,107.02 | 2,026.31 | 750.79 | 399.73 | 86.17 |
| Loan funds | |||||
| Secured loans | - | - | - | 0.02 | 0.02 |
| Unsecured loans | - | - | - | - | - |
| Total | 2,138.21 | 2,054.31 | 752.75 | 401.71 | 88.15 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 932.25 | 708.02 | 650.08 | 593.74 | 475.05 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 151.62 | 112.99 | 77.28 | 47.50 | 18.75 |
| Net block | 780.63 | 595.03 | 572.80 | 546.25 | 456.31 |
| Capital work-in-progress | 61.62 | 91.69 | 14.10 | 10.73 | 80.39 |
| Investments | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Net current assets | |||||
| Current assets, loans & advances | 1,859.83 | 1,784.21 | 1,410.10 | 1,168.55 | 938.62 |
| Less : current liabilities & provisions | 563.94 | 416.70 | 1,244.33 | 1,323.89 | 1,387.25 |
| Total net current assets | 1,295.89 | 1,367.52 | 165.77 | -155.34 | -448.63 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 2,138.21 | 2,054.31 | 752.75 | 401.71 | 88.15 |
| Notes: | |||||
| Book value of unquoted investments | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 12.83 | 50.42 | 17.23 | 38.93 | 187.29 |
| Number of equity sharesoutstanding (Lacs) | 1225.27 | 1225.27 | 98.00 | 19.60 | 4.60 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis